Evidence map›Paper›PMID 20449175›Full record

ArticleDalton transactions (Cambridge, England : 2003)2009

A theobromine derived silver N-heterocyclic carbene: synthesis, characterization, and antimicrobial efficacy studies on cystic fibrosis relevant pathogens.

Matthew J Panzner, Khadijah M Hindi, Brian D Wright, Jane B Taylor, Daniel S Han, Wiley J Youngs, Carolyn L Cannon

Open access · greenAbstract read
In one paragraph

Article in Dalton transactions (Cambridge, England : 2003), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. International journal of molecular sciences · 2019
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. The use ofMedChemComm · 2013
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Matthew J PanznerDepartment of Chemistry, The University of Akron, Akron, OH 44325-3601, USA.
Khadijah M Hindi
Brian D Wright
Jane B Taylor
Daniel S Han
Wiley J Youngs
Carolyn L Cannon
Washington University in St. Louis · USUniversity of Akron · US

Funding

Collaborative Research: Polymeric Drug Delivery Systems and Biofilms in the LungR01GM086895 · NIGMS · UNIVERSITY OF AKRON · PI YOUNG, GERALD W · 2008 to 2011
$1.5M
Silver carbene complexes as treatment of CF lung diseaseR01AI067856 · NIAID · WASHINGTON UNIVERSITY · PI CANNON, CAROLYN LOUISE · 2006 to 2008
$1.1M
NIAID NIH HHS R01 AI067856NIGMS NIH HHS 1 R01 GM86895-01NIGMS NIH HHS R01 GM086895PHS HHS 1 R01 A106785601
6 · The paper itself

Abstract

The increasing incidence of multidrug-resistant (MDR) pulmonary infections in the cystic fibrosis (CF) population has prompted the investigation of innovative silver based therapeutics. The functionalization of the naturally occurring xanthine theobromine at the N(1) nitrogen atom with an ethanol substituent followed by the methylation of the N(9) nitrogen atom gives the N-heterocyclic carbene precursor 1-(2-hydroxyethyl)-3,7,9-trimethylxanthinium iodide. The reaction of this xanthinium salt with silver acetate produces the highly hydrophilic silver carbene complex SCC8. The in vitro antimicrobial efficacy of this newly synthesized complex was evaluated with excellent results on a variety of virulent and MDR pathogens isolated from CF patients. A comparative in vivo study between the known caffeine derived silver carbene SCC1 and SCC8 demonstrated the ability of both complexes to improve the survival rates of mice in a pneumonia model utilizing the clinically isolated infectious strain of Pseudomonas aeruginosa PA M57-15.

Indexed as

AnimalsAnti-Bacterial AgentsCrystallography, X-RayCystic FibrosisDisease Models, AnimalDose-Response Relationship, DrugFemaleHeterocyclic CompoundsMethaneMiceMice, Inbred C57BLMicrobial Sensitivity TestsModels, MolecularMolecular StructureOrganometallic CompoundsPseudomonas aeruginosaAnti-Bacterial AgentscarbeneHeterocyclic CompoundsMethaneOrganometallic CompoundsSilverTheobromine

Identifiers

PMID20449175
PMCPMC2867067
OpenAlexW2070541630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.